Methimazole Dosing for a 56 kg Patient
For a 56 kg patient with hyperthyroidism, the appropriate methimazole dose depends on disease severity: 15 mg daily for mild hyperthyroidism, 30-40 mg daily for moderate disease, or 60 mg daily for severe hyperthyroidism, divided into three doses at 8-hour intervals. 1
Initial Dosing Strategy
The FDA-approved dosing provides clear guidance based on clinical severity 1:
- Mild hyperthyroidism: 15 mg/day total (5 mg three times daily)
- Moderately severe hyperthyroidism: 30-40 mg/day total (10-13.3 mg three times daily)
- Severe hyperthyroidism: 60 mg/day total (20 mg three times daily)
Practical Considerations
While the FDA label recommends divided dosing at 8-hour intervals, once-daily dosing is equally effective and improves compliance 2. The guidelines note that methimazole can be given once daily even in severe hyperthyroidism, with compliance rates of 83% for once-daily versus 53% for multiple daily doses 2.
For your 56 kg patient, this translates to weight-based dosing of approximately:
- Mild: 0.27 mg/kg/day
- Moderate: 0.54-0.71 mg/kg/day
- Severe: 1.07 mg/kg/day
Maintenance Dosing
Once thyroid hormone levels normalize, reduce the methimazole dose by 50% or more to maintain euthyroid status 2. The typical maintenance dose is 5-15 mg daily 1. Avoid "block-and-replace" regimens (continuing high-dose methimazole plus levothyroxine) as meta-analyses show higher adverse event rates 2.
Treatment Duration
Continue methimazole for approximately 12-18 months, then taper or discontinue if TSH is normal 2. Monitor thyroid function at 1-3 month intervals for 6-12 months after discontinuation to detect early relapse 2.
Critical Safety Monitoring
Before initiating therapy, obtain baseline complete blood count with differential and liver function tests 2. Instruct the patient to stop methimazole immediately and contact you if they develop: fever, sore throat, rash, jaundice, pale stools, dark urine, joint pain, or abdominal pain 2.
Common Pitfall
Do not routinely monitor white blood cell counts—only check during febrile illness or pharyngitis 2. Routine monitoring has not been shown to prevent agranulocytosis effectively.
Special Populations
For pregnancy: Use propylthiouracil in the first trimester due to methimazole's teratogenic risk (aplasia cutis, choanal/esophageal atresia), then switch to methimazole in the second trimester 2. For children: Use weight-based dosing of 0.2-0.5 mg/kg daily (range 0.1-1.0 mg/kg) 2.